Listed

LianBio

LIANYOTCCIK 1831283HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$26.3m, Q3 FY2023
Net income−$24.0m, Q3 FY2023
LianBio, income statement, quarterly
Line itemUnitperiod not labelled2020-12-31period not labelled2021-03-31period not labelled2021-06-30Q3 FY20212021-09-30Q4 FY20212021-12-31Q1 FY20222022-03-31Q2 FY20222022-06-30Q3 FY20222022-09-30Q4 FY20222022-12-31Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30
Research and development$m2.7Research and development, period not labelled, three months to 2020-12-31$2.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2022-03-31, accession 0001831283-22-000014. Derived: 12-month figure less the 9-month figure.Report this figure53.4Research and development, period not labelled, three months to 2021-03-31$53.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2022-05-12, accession 0001831283-22-000042.Report this figure93.0Research and development, period not labelled, three months to 2021-06-30$93.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2022-08-11, accession 0001831283-22-000061.Report this figure4.7Research and development, Q3 FY2021, three months to 2021-09-30$4.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2022-11-10, accession 0001831283-22-000075.Report this figure7.7Research and development, Q4 FY2021, three months to 2021-12-31$7.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2023-03-28, accession 0001831283-23-000041. Derived: 12-month figure less the 9-month figure.Report this figure12.3Research and development, Q1 FY2022, three months to 2022-03-31$12.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2023-05-11, accession 0001831283-23-000081.Report this figure28.6Research and development, Q2 FY2022, three months to 2022-06-30$28.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2023-08-14, accession 0001831283-23-000110.Report this figure8.3Research and development, Q3 FY2022, three months to 2022-09-30$8.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figure10.6Research and development, Q4 FY2022, three months to 2022-12-31$10.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2023-03-28, accession 0001831283-23-000041. Derived: 12-month figure less the 9-month figure.Report this figure10.8Research and development, Q1 FY2023, three months to 2023-03-31$10.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2023-05-11, accession 0001831283-23-000081.Report this figure9.5Research and development, Q2 FY2023, three months to 2023-06-30$9.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2023-08-14, accession 0001831283-23-000110.Report this figure9.0Research and development, Q3 FY2023, three months to 2023-09-30$9.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figure
Operating income$m(9.2)Operating income, period not labelled, three months to 2020-12-31−$9.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2022-03-31, accession 0001831283-22-000014. Derived: 12-month figure less the 9-month figure.Report this figure(60.5)Operating income, period not labelled, three months to 2021-03-31−$60.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2022-05-12, accession 0001831283-22-000042.Report this figure(99.5)Operating income, period not labelled, three months to 2021-06-30−$99.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2022-08-11, accession 0001831283-22-000061.Report this figure(13.5)Operating income, Q3 FY2021, three months to 2021-09-30−$13.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2022-11-10, accession 0001831283-22-000075.Report this figure(22.0)Operating income, Q4 FY2021, three months to 2021-12-31−$22.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2023-03-28, accession 0001831283-23-000041. Derived: 12-month figure less the 9-month figure.Report this figure(28.4)Operating income, Q1 FY2022, three months to 2022-03-31−$28.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2023-05-11, accession 0001831283-23-000081.Report this figure(43.1)Operating income, Q2 FY2022, three months to 2022-06-30−$43.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2023-08-14, accession 0001831283-23-000110.Report this figure(24.5)Operating income, Q3 FY2022, three months to 2022-09-30−$24.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figure(29.2)Operating income, Q4 FY2022, three months to 2022-12-31−$29.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2023-03-28, accession 0001831283-23-000041. Derived: 12-month figure less the 9-month figure.Report this figure(26.0)Operating income, Q1 FY2023, three months to 2023-03-31−$26.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2023-05-11, accession 0001831283-23-000081.Report this figure(25.0)Operating income, Q2 FY2023, three months to 2023-06-30−$25.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2023-08-14, accession 0001831283-23-000110.Report this figure(26.3)Operating income, Q3 FY2023, three months to 2023-09-30−$26.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figure
Income tax$m0.0Income tax, period not labelled, three months to 2020-12-31$2.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2022-03-31, accession 0001831283-22-000014. Derived: 12-month figure less the 9-month figure.Report this figure1.0Income tax, period not labelled, three months to 2021-03-31$975.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2022-05-12, accession 0001831283-22-000042.Report this figure1.0Income tax, period not labelled, three months to 2021-06-30$975.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2022-08-11, accession 0001831283-22-000061.Report this figure(0.4)Income tax, Q3 FY2021, three months to 2021-09-30−$397.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2022-11-10, accession 0001831283-22-000075.Report this figure(1.0)Income tax, Q4 FY2021, three months to 2021-12-31−$1.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2023-03-28, accession 0001831283-23-000041. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2022, three months to 2022-03-31$6.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2023-05-11, accession 0001831283-23-000081.Report this figure0.0Income tax, Q2 FY2022, three months to 2022-06-30$5.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2023-08-14, accession 0001831283-23-000110.Report this figure0.0Income tax, Q3 FY2022, three months to 2022-09-30$6.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figure(0.4)Income tax, Q4 FY2022, three months to 2022-12-31−$350.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2023-03-28, accession 0001831283-23-000041. Derived: 12-month figure less the 9-month figure.Report this figure0.4Income tax, Q1 FY2023, three months to 2023-03-31$438.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2023-05-11, accession 0001831283-23-000081.Report this figure0.2Income tax, Q2 FY2023, three months to 2023-06-30$200.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2023-08-14, accession 0001831283-23-000110.Report this figure0.6Income tax, Q3 FY2023, three months to 2023-09-30$586.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figure
Net income$m(12.7)Net income, period not labelled, three months to 2020-12-31−$12.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2022-03-31, accession 0001831283-22-000014. Derived: 12-month figure less the 9-month figure.Report this figure(61.6)Net income, period not labelled, three months to 2021-03-31−$61.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2022-11-10, accession 0001831283-22-000075.Report this figure(100)Net income, period not labelled, three months to 2021-06-30−$100.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2022-11-10, accession 0001831283-22-000075.Report this figure(13.1)Net income, Q3 FY2021, three months to 2021-09-30−$13.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2022-11-10, accession 0001831283-22-000075.Report this figure(21.2)Net income, Q4 FY2021, three months to 2021-12-31−$21.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2023-03-28, accession 0001831283-23-000041. Derived: 12-month figure less the 9-month figure.Report this figure(27.7)Net income, Q1 FY2022, three months to 2022-03-31−$27.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figure(42.4)Net income, Q2 FY2022, three months to 2022-06-30−$42.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figure(21.9)Net income, Q3 FY2022, three months to 2022-09-30−$21.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figure(18.3)Net income, Q4 FY2022, three months to 2022-12-31−$18.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2023-03-28, accession 0001831283-23-000041. Derived: 12-month figure less the 9-month figure.Report this figure(24.0)Net income, Q1 FY2023, three months to 2023-03-31−$24.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figure(21.6)Net income, Q2 FY2023, three months to 2023-06-30−$21.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figure(24.0)Net income, Q3 FY2023, three months to 2023-09-30−$24.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figure
Diluted EPS$ per sharenot reported(3.01)Diluted EPS, period not labelled, three months to 2021-03-31−$3.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2022-05-12, accession 0001831283-22-000042.Report this figure(4.90)Diluted EPS, period not labelled, three months to 2021-06-30−$4.90 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2022-08-11, accession 0001831283-22-000061.Report this figure(0.63)Diluted EPS, Q3 FY2021, three months to 2021-09-30−$0.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2022-11-10, accession 0001831283-22-000075.Report this figurenot reported(0.26)Diluted EPS, Q1 FY2022, three months to 2022-03-31−$0.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2023-05-11, accession 0001831283-23-000081.Report this figure(0.39)Diluted EPS, Q2 FY2022, three months to 2022-06-30−$0.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2023-08-14, accession 0001831283-23-000110.Report this figure(0.20)Diluted EPS, Q3 FY2022, three months to 2022-09-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figurenot reported(0.22)Diluted EPS, Q1 FY2023, three months to 2023-03-31−$0.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2023-05-11, accession 0001831283-23-000081.Report this figure(0.20)Diluted EPS, Q2 FY2023, three months to 2023-06-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2023-08-14, accession 0001831283-23-000110.Report this figure(0.22)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figure
Basic EPS$ per sharenot reported(3.01)Basic EPS, period not labelled, three months to 2021-03-31−$3.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2022-05-12, accession 0001831283-22-000042.Report this figure(4.90)Basic EPS, period not labelled, three months to 2021-06-30−$4.90 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2022-08-11, accession 0001831283-22-000061.Report this figure(0.63)Basic EPS, Q3 FY2021, three months to 2021-09-30−$0.63 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2022-11-10, accession 0001831283-22-000075.Report this figurenot reported(0.26)Basic EPS, Q1 FY2022, three months to 2022-03-31−$0.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2023-05-11, accession 0001831283-23-000081.Report this figure(0.39)Basic EPS, Q2 FY2022, three months to 2022-06-30−$0.39 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2023-08-14, accession 0001831283-23-000110.Report this figure(0.20)Basic EPS, Q3 FY2022, three months to 2022-09-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figurenot reported(0.22)Basic EPS, Q1 FY2023, three months to 2023-03-31−$0.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2023-05-11, accession 0001831283-23-000081.Report this figure(0.20)Basic EPS, Q2 FY2023, three months to 2023-06-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2023-08-14, accession 0001831283-23-000110.Report this figure(0.22)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figure

Balance sheet

Cash and equivalents$103.5m, Q3 FY2023
Shareholders' equity$202.3m, Q3 FY2023
LianBio, balance sheet, quarterly
Line itemUnitperiod not labelled2020-12-31period not labelled2021-03-31period not labelled2021-06-30Q3 FY20212021-09-30FY20212021-12-31Q1 FY20222022-03-31Q2 FY20222022-06-30Q3 FY20222022-09-30FY20222022-12-31Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30
Cash and equivalents$m254Cash and equivalents, period not labelled, at 2020-12-31$254.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2022-03-31, accession 0001831283-22-000014.Report this figure235Cash and equivalents, period not labelled, at 2021-03-31$235.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2022-05-12, accession 0001831283-22-000042.Report this figure143Cash and equivalents, period not labelled, at 2021-06-30$142.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2022-08-11, accession 0001831283-22-000061.Report this figure109Cash and equivalents, Q3 FY2021, at 2021-09-30$109.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2022-11-10, accession 0001831283-22-000075.Report this figure228Cash and equivalents, FY2021, at 2021-12-31$228.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2023-03-28, accession 0001831283-23-000041.Report this figure140Cash and equivalents, Q1 FY2022, at 2022-03-31$139.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-05-11, accession 0001831283-23-000081.Report this figure134Cash and equivalents, Q2 FY2022, at 2022-06-30$134.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-08-14, accession 0001831283-23-000110.Report this figure78.9Cash and equivalents, Q3 FY2022, at 2022-09-30$78.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figure79.2Cash and equivalents, FY2022, at 2022-12-31$79.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figure102Cash and equivalents, Q1 FY2023, at 2023-03-31$102.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-05-11, accession 0001831283-23-000081.Report this figure104Cash and equivalents, Q2 FY2023, at 2023-06-30$104.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-08-14, accession 0001831283-23-000110.Report this figure103Cash and equivalents, Q3 FY2023, at 2023-09-30$103.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figure
Current assets$m277Current assets, period not labelled, at 2020-12-31$276.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2022-03-31, accession 0001831283-22-000014.Report this figurenot reportednot reported121Current assets, Q3 FY2021, at 2021-09-30$121.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q/A filed 2022-01-10, accession 0001193125-22-005640.Report this figure400Current assets, FY2021, at 2021-12-31$399.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2023-03-28, accession 0001831283-23-000041.Report this figure386Current assets, Q1 FY2022, at 2022-03-31$386.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2022-05-12, accession 0001831283-22-000042.Report this figure344Current assets, Q2 FY2022, at 2022-06-30$343.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2022-08-11, accession 0001831283-22-000061.Report this figure324Current assets, Q3 FY2022, at 2022-09-30$324.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2022-11-10, accession 0001831283-22-000075.Report this figure313Current assets, FY2022, at 2022-12-31$312.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figure296Current assets, Q1 FY2023, at 2023-03-31$296.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-05-11, accession 0001831283-23-000081.Report this figure273Current assets, Q2 FY2023, at 2023-06-30$273.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-08-14, accession 0001831283-23-000110.Report this figure258Current assets, Q3 FY2023, at 2023-09-30$257.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figure
Total assets$m279Total assets, period not labelled, at 2020-12-31$279.3m. XBRL concept us-gaap:Assets. 10-K filed 2022-03-31, accession 0001831283-22-000014.Report this figurenot reportednot reported142Total assets, Q3 FY2021, at 2021-09-30$141.9m. XBRL concept us-gaap:Assets. 10-Q/A filed 2022-01-10, accession 0001193125-22-005640.Report this figure426Total assets, FY2021, at 2021-12-31$426.3m. XBRL concept us-gaap:Assets. 10-K filed 2023-03-28, accession 0001831283-23-000041.Report this figure413Total assets, Q1 FY2022, at 2022-03-31$413.5m. XBRL concept us-gaap:Assets. 10-Q filed 2022-05-12, accession 0001831283-22-000042.Report this figure372Total assets, Q2 FY2022, at 2022-06-30$371.8m. XBRL concept us-gaap:Assets. 10-Q filed 2022-08-11, accession 0001831283-22-000061.Report this figure352Total assets, Q3 FY2022, at 2022-09-30$351.8m. XBRL concept us-gaap:Assets. 10-Q filed 2022-11-10, accession 0001831283-22-000075.Report this figure320Total assets, FY2022, at 2022-12-31$320.0m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figure303Total assets, Q1 FY2023, at 2023-03-31$302.6m. XBRL concept us-gaap:Assets. 10-Q filed 2023-05-11, accession 0001831283-23-000081.Report this figure279Total assets, Q2 FY2023, at 2023-06-30$278.8m. XBRL concept us-gaap:Assets. 10-Q filed 2023-08-14, accession 0001831283-23-000110.Report this figure263Total assets, Q3 FY2023, at 2023-09-30$262.9m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figure
Current liabilities$m6.2Current liabilities, period not labelled, at 2020-12-31$6.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2022-03-31, accession 0001831283-22-000014.Report this figurenot reportednot reported22.3Current liabilities, Q3 FY2021, at 2021-09-30$22.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q/A filed 2022-01-10, accession 0001193125-22-005640.Report this figure15.1Current liabilities, FY2021, at 2021-12-31$15.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2023-03-28, accession 0001831283-23-000041.Report this figure25.2Current liabilities, Q1 FY2022, at 2022-03-31$25.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2022-05-12, accession 0001831283-22-000042.Report this figure21.7Current liabilities, Q2 FY2022, at 2022-06-30$21.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2022-08-11, accession 0001831283-22-000061.Report this figure22.0Current liabilities, Q3 FY2022, at 2022-09-30$22.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2022-11-10, accession 0001831283-22-000075.Report this figure23.6Current liabilities, FY2022, at 2022-12-31$23.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figure25.9Current liabilities, Q1 FY2023, at 2023-03-31$25.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-05-11, accession 0001831283-23-000081.Report this figure21.6Current liabilities, Q2 FY2023, at 2023-06-30$21.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-08-14, accession 0001831283-23-000110.Report this figure25.6Current liabilities, Q3 FY2023, at 2023-09-30$25.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figure
Total liabilities$m27.6Total liabilities, period not labelled, at 2020-12-31$27.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2022-03-31, accession 0001831283-22-000014.Report this figurenot reportednot reported42.3Total liabilities, Q3 FY2021, at 2021-09-30$42.3m. XBRL concept us-gaap:Liabilities. 10-Q/A filed 2022-01-10, accession 0001193125-22-005640.Report this figure39.0Total liabilities, FY2021, at 2021-12-31$39.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2023-03-28, accession 0001831283-23-000041.Report this figure48.7Total liabilities, Q1 FY2022, at 2022-03-31$48.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2022-05-12, accession 0001831283-22-000042.Report this figure45.6Total liabilities, Q2 FY2022, at 2022-06-30$45.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2022-08-11, accession 0001831283-22-000061.Report this figure45.2Total liabilities, Q3 FY2022, at 2022-09-30$45.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2022-11-10, accession 0001831283-22-000075.Report this figure26.3Total liabilities, FY2022, at 2022-12-31$26.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figure28.2Total liabilities, Q1 FY2023, at 2023-03-31$28.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-05-11, accession 0001831283-23-000081.Report this figure23.3Total liabilities, Q2 FY2023, at 2023-06-30$23.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-08-14, accession 0001831283-23-000110.Report this figure26.8Total liabilities, Q3 FY2023, at 2023-09-30$26.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figure
Shareholders' equity$m(133)Shareholders' equity, period not labelled, at 2020-12-31−$132.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2022-03-31, accession 0001831283-22-000014.Report this figure(149)Shareholders' equity, period not labelled, at 2021-03-31−$148.5m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2022-11-10, accession 0001831283-22-000075.Report this figure(247)Shareholders' equity, period not labelled, at 2021-06-30−$247.4m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2022-11-10, accession 0001831283-22-000075.Report this figure(297)Shareholders' equity, Q3 FY2021, at 2021-09-30−$297.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q/A filed 2022-01-10, accession 0001193125-22-005640.Report this figure354Shareholders' equity, FY2021, at 2021-12-31$353.6m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2023-03-28, accession 0001831283-23-000041.Report this figure331Shareholders' equity, Q1 FY2022, at 2022-03-31$331.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2022-05-12, accession 0001831283-22-000042.Report this figure292Shareholders' equity, Q2 FY2022, at 2022-06-30$292.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2022-08-11, accession 0001831283-22-000061.Report this figure273Shareholders' equity, Q3 FY2022, at 2022-09-30$272.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2022-11-10, accession 0001831283-22-000075.Report this figure260Shareholders' equity, FY2022, at 2022-12-31$259.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figure241Shareholders' equity, Q1 FY2023, at 2023-03-31$240.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-05-11, accession 0001831283-23-000081.Report this figure222Shareholders' equity, Q2 FY2023, at 2023-06-30$221.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-08-14, accession 0001831283-23-000110.Report this figure202Shareholders' equity, Q3 FY2023, at 2023-09-30$202.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figure

Cash flow

Operating cash flow−$15.9m, Q3 FY2023
Capital expenditure$160.0k, Q3 FY2023
LianBio, cash flow, quarterly
Line itemUnitperiod not labelled2020-12-31period not labelled2021-03-31period not labelled2021-06-30Q3 FY20212021-09-30Q4 FY20212021-12-31Q1 FY20222022-03-31Q2 FY20222022-06-30Q3 FY20222022-09-30Q4 FY20222022-12-31Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30
Operating cash flow$m(48.9)Operating cash flow, period not labelled, three months to 2020-12-31−$48.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2022-03-31, accession 0001831283-22-000014. Derived: 12-month figure less the 9-month figure.Report this figure(1.9)Operating cash flow, period not labelled, three months to 2021-03-31−$1.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2022-05-12, accession 0001831283-22-000042.Report this figure(92.9)Operating cash flow, period not labelled, three months to 2021-06-30−$92.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2022-08-11, accession 0001831283-22-000061. Derived: 6-month figure less the 3-month figure.Report this figure(38.8)Operating cash flow, Q3 FY2021, three months to 2021-09-30−$38.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2022-11-10, accession 0001831283-22-000075. Derived: 9-month figure less the 6-month figure.Report this figure(30.4)Operating cash flow, Q4 FY2021, three months to 2021-12-31−$30.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2023-03-28, accession 0001831283-23-000041. Derived: 12-month figure less the 9-month figure.Report this figure(13.1)Operating cash flow, Q1 FY2022, three months to 2022-03-31−$13.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2023-05-11, accession 0001831283-23-000081.Report this figure(39.4)Operating cash flow, Q2 FY2022, three months to 2022-06-30−$39.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2023-08-14, accession 0001831283-23-000110. Derived: 6-month figure less the 3-month figure.Report this figure(16.0)Operating cash flow, Q3 FY2022, three months to 2022-09-30−$16.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2023-11-13, accession 0001831283-23-000126. Derived: 9-month figure less the 6-month figure.Report this figure(30.7)Operating cash flow, Q4 FY2022, three months to 2022-12-31−$30.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2023-03-28, accession 0001831283-23-000041. Derived: 12-month figure less the 9-month figure.Report this figure(17.6)Operating cash flow, Q1 FY2023, three months to 2023-03-31−$17.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2023-05-11, accession 0001831283-23-000081.Report this figure(19.3)Operating cash flow, Q2 FY2023, three months to 2023-06-30−$19.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2023-08-14, accession 0001831283-23-000110. Derived: 6-month figure less the 3-month figure.Report this figure(15.9)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$15.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2023-11-13, accession 0001831283-23-000126. Derived: 9-month figure less the 6-month figure.Report this figure
Capital expenditure$m0.6Capital expenditure, period not labelled, three months to 2020-12-31$551.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2022-03-31, accession 0001831283-22-000014. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, period not labelled, three months to 2021-03-31$29.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2022-05-12, accession 0001831283-22-000042.Report this figure0.0Capital expenditure, period not labelled, three months to 2021-06-30$38.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2022-08-11, accession 0001831283-22-000061. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2021, three months to 2021-09-30$92.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2022-11-10, accession 0001831283-22-000075. Derived: 9-month figure less the 6-month figure.Report this figure0.8Capital expenditure, Q4 FY2021, three months to 2021-12-31$788.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2023-03-28, accession 0001831283-23-000041. Derived: 12-month figure less the 9-month figure.Report this figure0.3Capital expenditure, Q1 FY2022, three months to 2022-03-31$344.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2023-05-11, accession 0001831283-23-000081.Report this figure0.3Capital expenditure, Q2 FY2022, three months to 2022-06-30$329.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2023-08-14, accession 0001831283-23-000110. Derived: 6-month figure less the 3-month figure.Report this figure0.9Capital expenditure, Q3 FY2022, three months to 2022-09-30$937.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2023-11-13, accession 0001831283-23-000126. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2022, three months to 2022-12-31$235.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2023-03-28, accession 0001831283-23-000041. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2023, three months to 2023-03-31$19.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2023-05-11, accession 0001831283-23-000081.Report this figure0.1Capital expenditure, Q2 FY2023, three months to 2023-06-30$50.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2023-08-14, accession 0001831283-23-000110. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2023, three months to 2023-09-30$160.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2023-11-13, accession 0001831283-23-000126. Derived: 9-month figure less the 6-month figure.Report this figure

Shares

Diluted shares (weighted)107.17m, Q3 FY2023
LianBio, shares, quarterly
Line itemUnitperiod not labelled2021-03-31period not labelled2021-06-30Q3 FY20212021-09-30Q1 FY20222022-03-31Q2 FY20222022-06-30Q3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30
Diluted shares (weighted)m shares20.5Diluted shares (weighted), period not labelled, three months to 2021-03-3120,477,338 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2022-05-12, accession 0001831283-22-000042.Report this figure20.5Diluted shares (weighted), period not labelled, three months to 2021-06-3020,477,338 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2022-08-11, accession 0001831283-22-000061.Report this figure20.7Diluted shares (weighted), Q3 FY2021, three months to 2021-09-3020,690,908 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2022-11-10, accession 0001831283-22-000075.Report this figure107Diluted shares (weighted), Q1 FY2022, three months to 2022-03-31107,275,458 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-05-11, accession 0001831283-23-000081.Report this figure108Diluted shares (weighted), Q2 FY2022, three months to 2022-06-30107,922,501 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-08-14, accession 0001831283-23-000110.Report this figure108Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30108,353,831 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figure107Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31107,162,025 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-05-11, accession 0001831283-23-000081.Report this figure107Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30107,164,401 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-08-14, accession 0001831283-23-000110.Report this figure107Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30107,167,691 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figure

Shares outstanding: 108.06mShares outstanding, period not labelled, at 2023-11-09108,062,638 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2023-11-13, accession 0001831283-23-000126.Report this figure at Nov 9, 2023, from the cover of the 10-Q filed Nov 13, 2023.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.